FemGen
The FemGen test is a genetic analysis that enables the effective determination of the risk of adverse reactions to medications associated with hormone replacement therapy. The results of this test will provide you with detailed information about which treatment to choose for the best response.
ABOUT FEMGEN
FemGen tests all enzymatic systems involved in the elimination of estrogens, including the production of biological estrogen and complete detoxification. The FemGen test was developed to prevent complications associated with hormone replacement therapy.
WHO AND WHEN SHOULD BE TESTED?
FemGen is designed for women considering hormone replacement therapy, particularly those with a history of breast cancer. This test will provide you with personalized recommendations based on the analysis of genetic predispositions.
RESULTS AND INTERPRETATION
The FemGen test is based exclusively on genetic analysis conducted using a blood or saliva sample.
– Detailed individual results that are valid for a lifetime
– Personalized prevention recommendations
– Detailed information regarding any relevant genetic variations
– Customized treatment recommendations.